FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Lannett Company, Inc.)

View source ↗

Summary

FDA approved a supplemental application for montelukast sodium from Lannett Company, Inc., indicating approval of a supplemental (generic) filing under an ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Asthma
• Exercise-induced Bronchoconstriction

Drugs mentioned

• Montelukast Sodium (Montelukast Sodium)

Snippet

SUPPL AP for MONTELUKAST SODIUM (MONTELUKAST SODIUM)